FDA NDC Directory · JSON-LD · Markdown

Amoxicillin and Clavulanate Potassium

NDC 0093-2277 · HUMAN PRESCRIPTION DRUG · POWDER, FOR SUSPENSION

Labeler / ManufacturerTeva Pharmaceuticals USA, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA065089
Dosage form / routePOWDER, FOR SUSPENSION · ORAL
Active ingredientsAMOXICILLIN (200 mg/5mL)
CLAVULANATE POTASSIUM (28.5 mg/5mL)
Marketing started20050113
Package count1

External sources

Source: openFDA. Public-domain (CC0).